Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

Corporate Governance Structure

Company Overview

(As of March 31, 2018)
Company Overview
Type Announcement
Representative Seung-kook Park, Jae-chun Yoon
Established on November 20th 1973
Listed on December 18th 1989 (listed on the securities market of the stock exchange)
Largest Shareholder Daewoong Pharmaceutical Co., Ltd.
Capital 26.1 billion KRW
Nominal Value 500 KRW
Total Issued Stocks 52,240,638
Number of Employees 315

Board of Directors

(As of March 31, 2018)
Board of Directors
Type Position Name Term Background Remarks
Executive Directors Chairman & CEO Jae-chun Yoon 3 years CEO of Daewoong Co., Ltd.
CEO Seung-kook Park 3 years Chief Director of Bio Research Center of Daewoong Pharmaceutical Co., Ltd.
Executive Director Sung-wuk Kim 3 years CEO of Hanall Bio Pharma Co., Ltd.
Executive Director Bong-yong Lee 3 years Chief Director of R&D Division of Daewoong Pharmaceutical Co., Ltd.
Non-executive Directors Independent Director Seong-jong Jo 3 years tax accountant at Jo Seong-jong Accounting Firm Head of Audit Committee
Independent Director Jin-hyeong Kim 3 years Samdo Accounting Firm Partner Member of Audit Committee
Independent Director Sung-sub Kim 3 years Director of Chungnam National Univ. Graduate School of Drug Development and Discovery Member of Audit Committee